Recombinant polypeptides and vaccines for preventing and treating Eimeria spp.
A recombinant polypeptide and vaccine technology, applied in vaccines, recombinant DNA technology, and microbial-based methods, can solve problems such as no systematic understanding of coccidia and host cells, difficulties in the development of new anticoccidial drugs and molecular vaccines, and achieve control Chicken coccidiosis and the effect of reducing the amount of use
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0032] The present invention also relates to the preparation method of the above-mentioned recombinant polypeptide, comprising:
[0033] Cultivate the above-mentioned host cells under appropriate conditions, collect the culture medium and / or the lysate of the host cells, separate and purify to obtain the recombinant polypeptide.
[0034] The present invention also relates to a vaccine comprising a recombinant polypeptide as described above, a nucleic acid as described above or a vector as described above.
[0035] In some embodiments, the vaccine further comprises an adjuvant and / or a pharmaceutically acceptable carrier.
[0036] As used herein, an "adjuvant" is a substance that facilitates or amplifies a cascade of immunological events that ultimately leads to a better immune response, ie, an integrated body response against an antigen. An adjuvant is not usually required for an immune response to occur, but facilitates or amplifies it.
[0037]Adjuvants can also be aluminu...
Embodiment
[0057] 1 Preparation of EA-FLTI coding gene
[0058] 1.1 Optimization of coding genes
[0059] According to the bioinformatics analysis of the related genes encoded by the Eimeria heaperia micronematin and the rod neck protein obtained by the applicant team, the rod neck protein 2 (109 amino acids) and the rod neck protein 1 were screened. (202 amino acids) and 2 (206 amino acids) and as candidate tandem polypeptides, the amino acid sequence is as shown in SEQ ID NO: 3, codon optimization is carried out for different hosts, and the prokaryotic expression coding gene sequences are respectively obtained, such as SEQ ID NO: 1, and the eukaryotic expression coding gene sequence, as shown in SEQ ID NO:2.
[0060] 1.2 Synthesis of coding genes
[0061] The EA-FLTI prokaryotic coding gene (SEQ ID NO: 1) and eukaryotic coding gene (SEQ ID NO: 2) were prepared using the whole gene synthesis technology, and the T vector plasmids (pMD18-T-EA-FLTI1 and pMD18- T-EA-FLTI2).
[0062] 2 P...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


